Identification of major CYP2C9 and CYP2C19 polymorphisms by fluorescence resonance energy transfer analysis

Clinical Chemistry

Volumn 48, Issue 9, 2002, Pages 1592-1594

  Borlak, Jürgen ^a   Thum, Thomas ^a  

^a FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; BARBITURIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; WARFARIN; XENOBIOTIC AGENT;

ALLELE; ARTICLE; CHEMICAL REACTION; DNA DENATURATION; DNA HYBRIDIZATION; DRUG INDUCED DISEASE; DRUG METABOLISM; ENERGY TRANSFER; FLUORESCENCE; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MELTING POINT; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; STOP CODON;

EID: 0036721327     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.9.1592     Document Type: Article

References (12)

1. Biochemistry and molecular biology of the human CYP2C subfamily
2. Genetic susceptibility to adverse drug reactions
3. Genetic analysis of the human cytochrome P450 CYP2C9 locus
4. Allelic, genotypic and phenotypic distributions of S-mephenytoin 4′-hydroxylase (CYP2C19) in healthy Caucasian populations of European descent throughout the world
5. Identification of a null allele of CYP2C9 in an African-American exhibiting toxicity to phenytoin
6. Frequencies of defective CYP2C19 alleles in a Hong Kong Chinese population: Detection of the rare allele CYP2C19*4
7. Polymerase chain reaction-single-strand conformation polymorphism based determination of two major genetic defects responsible for a phenotypic polymorphism of cytochrome P450 (CYP) 2C19 in the Japanese population
8. High throughput detection of drug-metabolizing enzyme polymorphisms by allele-specific fluorogenic 5′ nuclease chain reaction assay
9. Use of single nucleotide polymorphisms (SNP) and real-time polymerase chain reaction for bone marrow engraftment analysis
10. Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects
11. The effect of genetic polymorphism of cytochrome P450 CYP2C9 on phenytoin dose requirement